TY - JOUR
T1 - Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction
AU - Gaballa, Mohamed A.
AU - Raya, Thomas E.
AU - Hoover, Craig A.
AU - Goldman, Steven
N1 - Funding Information:
This study was supported by grants from the Veterans Administration, Arizona Disease Control Research Commission (82-0697), the American Heart Association, The Wyss Foundation, the WARMER Foundation, and the Biomedical Research Foundation of Southern Arizona. We express our thanks to Maribeth Stansifer and Howard Byrne for their technical assistance and to Christopher Jacob for his help in data analysis and graphs presentation.
PY - 1999/6
Y1 - 1999/6
N2 - Objectives: To examine the relative roles of eNOS and iNOS (endothelial and inducible nitric oxide synthases) on basal and β-adrenergic receptor (β-AR)-stimulated arterial hemodynamic responses after myocardial infarction (MI). Methods: Left ventricular (LV) pressures and steady-state and pulsatile arterial hemodynamics were measured at baseline, and after acute NOS inhibition with either N(G)-nitro-L-arginine methyl ester (L-NAME, 100 mg/kg) or iNOS inhibition with aminoguanidine (AG, 75 mg/kg) in sham-operated and MI Sprague-Dawley rats. Results: In sham rats, L-NAME decreased (P<0.05) peak positive LV dP/dt and aortic blood velocity by 19% and 53%, respectively, and increased (P<0.05) mean arterial pressure (MAP), systemic vascular resistance, and LV end-diastolic pressure (EDP) by 20, 189 and 89%, respectively. The frequency-dependent components of hemodynamics including aortic input impedance modulus, characteristic impedance, and phase shift were increased (P<0.05) with L-NAME, while pulsatile power was decreased (P<0.05). AG increased (P<0.05) aortic input impedance modulus and characteristic impedance but had no effect on any other hemodynamic variable. In MI rats, L-NAME decreased (P<0.05) LV dP/dt and aortic blood velocity by 22 and 55%; respectively, and increased (P<0.05) SVR by 108%. There was no effect of L-NAME on MAP or LV EDP in MI rats. After MI, AG increased (P<0.05) heart rate and LV dP/dt but had no effect on other LV or pulsatile hemodynamic variables. Compared to Sham rats, heart rate, LV dP/dt, and blood velocity-isoproterenol close responses were shifted downward (P<0.05), while SVR-isoproterenol dose response was shifted upward (P<0.05) in MI rats. In sham rats, L-NAME potentiated (P<0.05, at >10-2 μg/kg) the isoproterenol- induced increase in LV dP/dt and aortic blood velocity, and potentiated (P<0.05) the isoproterenol-induced decline in SVR. AS expected, AG had no effects on isoproterenol-stimulated hemodynamics in sham rats. After MI, there was no effect of L-NAME or AG on isoproterenol-stimulated hemodynamics. Conclusions: (1) Circulatory and cardiac responses to inhibition of NO by L- NAME suggest that eNOS, but not iNOS, is the principal regulator of integrated arterial hemodynamic function in rats. (2) Both basal and β-AR- stimulated NO regulation of hemodynamic are attenuated after MI. (3) The attenuation of arterial hemodynamic effects after isoproterenol is mediated, in part, by alterations in the β-AR-activation of eNOS system after MI.
AB - Objectives: To examine the relative roles of eNOS and iNOS (endothelial and inducible nitric oxide synthases) on basal and β-adrenergic receptor (β-AR)-stimulated arterial hemodynamic responses after myocardial infarction (MI). Methods: Left ventricular (LV) pressures and steady-state and pulsatile arterial hemodynamics were measured at baseline, and after acute NOS inhibition with either N(G)-nitro-L-arginine methyl ester (L-NAME, 100 mg/kg) or iNOS inhibition with aminoguanidine (AG, 75 mg/kg) in sham-operated and MI Sprague-Dawley rats. Results: In sham rats, L-NAME decreased (P<0.05) peak positive LV dP/dt and aortic blood velocity by 19% and 53%, respectively, and increased (P<0.05) mean arterial pressure (MAP), systemic vascular resistance, and LV end-diastolic pressure (EDP) by 20, 189 and 89%, respectively. The frequency-dependent components of hemodynamics including aortic input impedance modulus, characteristic impedance, and phase shift were increased (P<0.05) with L-NAME, while pulsatile power was decreased (P<0.05). AG increased (P<0.05) aortic input impedance modulus and characteristic impedance but had no effect on any other hemodynamic variable. In MI rats, L-NAME decreased (P<0.05) LV dP/dt and aortic blood velocity by 22 and 55%; respectively, and increased (P<0.05) SVR by 108%. There was no effect of L-NAME on MAP or LV EDP in MI rats. After MI, AG increased (P<0.05) heart rate and LV dP/dt but had no effect on other LV or pulsatile hemodynamic variables. Compared to Sham rats, heart rate, LV dP/dt, and blood velocity-isoproterenol close responses were shifted downward (P<0.05), while SVR-isoproterenol dose response was shifted upward (P<0.05) in MI rats. In sham rats, L-NAME potentiated (P<0.05, at >10-2 μg/kg) the isoproterenol- induced increase in LV dP/dt and aortic blood velocity, and potentiated (P<0.05) the isoproterenol-induced decline in SVR. AS expected, AG had no effects on isoproterenol-stimulated hemodynamics in sham rats. After MI, there was no effect of L-NAME or AG on isoproterenol-stimulated hemodynamics. Conclusions: (1) Circulatory and cardiac responses to inhibition of NO by L- NAME suggest that eNOS, but not iNOS, is the principal regulator of integrated arterial hemodynamic function in rats. (2) Both basal and β-AR- stimulated NO regulation of hemodynamic are attenuated after MI. (3) The attenuation of arterial hemodynamic effects after isoproterenol is mediated, in part, by alterations in the β-AR-activation of eNOS system after MI.
KW - Blood flow
KW - Heart failure
KW - Nitric oxide
KW - β-Adrenergic receptors
UR - http://www.scopus.com/inward/record.url?scp=0033057776&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033057776&partnerID=8YFLogxK
U2 - 10.1016/S0008-6363(98)00343-5
DO - 10.1016/S0008-6363(98)00343-5
M3 - Article
C2 - 10533602
AN - SCOPUS:0033057776
SN - 0008-6363
VL - 42
SP - 627
EP - 635
JO - Cardiovascular research
JF - Cardiovascular research
IS - 3
ER -